Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01781013 · ClinicalTrials.gov registry record · NA

Diabetes-Depression Care-management Adoption Trial

A NA study of Depression and Diabetes Mellitus, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
1,485
Enrollment target
8
Study locations

NCT01781013 is a NA study of Depression and Diabetes Mellitus that has completed, run by University of Southern California. The registered enrollment target is 1,485 participants, above the 784-participant average among 679 other Depression trials with a reported enrollment target (89% higher). The trial reports 8 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01781013, a NA study of Depression and Diabetes Mellitus, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
1,485 participants
Enrollment target
8
Study locations

Study Summary

The specific aims of the proposed study are to: 1. Develop the innovative depression care management technology, including the speech recognition technology for automated monitoring and patient prompts over time, automatic integration of the responses into the patient registry, and evidence-based decision-support algorithms for care actions; 2. Conduct the quasi-experiment in eight Los Angeles County Department of Health Services (LAC-DHS) clinics to test the interventions; 3. Use mixed-method evaluation to assess the extent of the implementation of the interventions, the acceptance to the providers and to the patients, and the impact on adoption of depression screening and treatment management over time, utilization, and cost of healthcare services, and patient health outcomes; and 4. Conduct a cost-effectiveness analysis of the three study arms. Successful completion of the study will demonstrate which Comparative Effectiveness Research (CER) adoption strategies are successful and why, their comparative cost-effectiveness, as well as which strategies are successful under which circumstances to inform system-wide implementation of same. Hypotheses of the Proposed Study The following are the main hypotheses of the study: 1. There will be statistically significant difference in the adoption of depression care screening and management over time among the three study groups. 1.1. The adoption rate will be Technology-supported care (TC) \> Supported Care (SC) \> Usual Care (UC). 2. There will be statistically significant difference in the depression symptom reduction, and better functional status, and quality of life among the three study groups. 2.1. The difference between the TC and the SC will not be statistically significant, but both will be greater than the UC group. 3. There will be statistically significant difference in the diabetes care process and outcomes among the three study groups. 3.1. The difference between the TC and the SC will not be

Interventions

  • OTHER Technology-supported care

Study Locations (8)

California

  • El Monte Comprehensive Health Center - El Monte
  • High Desert Comprehensive Health Center - Lancaster
  • Long Beach Comprehensive Health Center - Long Beach
  • H. Claude Hudson Comprehensive Health Center - Los Angeles
  • Roybal Comprehensive Health Center - Los Angeles
  • Olive View-UCLA Medical Center Diabetes Clinic - Sylmar
  • Mid-Valley Comprehensive Health Center - Van Nuys
  • Harbor Comprehensive Health Center - Wilmington

Trial Details

FieldValue
Enrollment Target 1,485 participants
Start Date 2010-06
Est. Completion 2013-09
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT01781013

The ClinicalTrials.gov registry entry for NCT01781013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,485 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 784-participant average among 679 other Depression trials with a reported enrollment target (89% higher). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Technology-supported care is the first listed.

NCT01781013 reports 8 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01781013 about?

NCT01781013 is a clinical study titled "Diabetes-Depression Care-management Adoption Trial". The specific aims of the proposed study are to: 1. Develop the innovative depression care management technology, including the speech recognition technology for automated monitoring and patient prompts over time, automatic integration of the responses into the patient registry, and evidence-based d...

What is the current status of trial NCT01781013?

This trial is currently completed. It is a NA study. The enrollment target is 1,485 participants. The study started on 2010-06. Estimated completion is 2013-09.

What conditions does trial NCT01781013 study?

This clinical trial studies the following conditions: Depression, Diabetes Mellitus.

What interventions are being tested in trial NCT01781013?

The interventions under investigation include: Technology-supported care (OTHER).

Who is sponsoring clinical trial NCT01781013?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01781013 being conducted?

This trial has 8 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.